Background: Extended-spectrum b-lactamases (ESBLs) belonging to the SHV family remain a major cause of ESBL-positive phenotypes in Klebsiella pneumoniae. The bla SHV gene is a normal constituent of the K. pneumoniae chromosome. However, most ESBL-encoding bla SHV genes found in K. pneumoniae are plasmid borne. The objective was to determine the contribution of promoter variants to the expression of plasmid-borne bla SHV genes.
Introduction
bla SHV is present on the chromosome of virtually all Klebsiella pneumoniae.
1 Ford and Avison 2 have revealed that extant plasmid-encoded bla SHV genes are principally descended from the products of two different IS26-mediated chromosome!plasmid mobilization events. The two IS26 mobilized fragments differ in size and have the structure of compound transposons. We term these the 'large' and 'small' SHV transposons ( Figure 1 ). Selective pressure from third-generation cephalosporins has led to the appearance of the same codon 238 and 240 extended-spectrum b-lactamase (ESBL) activity-conferring mutations in both lineages. SHV ESBL expression is nearly always from plasmid-borne bla SHV . The reason is not clear. However, in vitro selection of an SHV-dependent ESBL-positive phenotype in K. pneumoniae is only possible with isolates that harbour a non-ESBL-encoding plasmid-borne bla SHV . 3 This may be due to enhanced expression of plasmid-borne bla SHV , which in turn is due to enhanced copy number and/or promoter activity. It is already known that the small SHV transposon has a strong promoter that was generated by insertion of IS26 into the bla SHV promoter region. 4 However, the large SHV transposon possesses a bla SHV promoter sequence remote from and unaltered by IS26 insertion. A bla SHV promoter-up mutation has been described, but this is chromosomally located.
The objectives of this study were to determine if the large SHV transposon harbours a bla SHV promoter with enhanced activity and to develop a rapid method for discriminating bla SHV promoter variants.
Methods

Bacterial isolates
K. pneumoniae clinical isolates were used throughout this study [ Table 1 and Table S1 , available as Supplementary data at JAC Online (http://jac.oxfordjournals.org)]. They were all derived from the Asia-Pacific SENTRY collection. 6 ESBL phenotypes were determined using standard methods. 7 All isolates were cultured in Luria -Bertani (LB) broth and stored in cryo vials with 12% glycerol at 2808C.
DNA extraction
DNA extraction was performed by using either a DNeasy tissue kit (Qiagen, Hilden, Germany) or a Corbett X-Tractor Gene robot (Corbett Robotics, Brisbane, Australia), both according to the manufacturer's instructions.
PCRs and DNA sequencing
The annealing locations, orientations and sequences of the PCR primers are shown in Figure 1 . Specific IS26 insertions were detected as described by Hammond et al. 3 using primers SHV5-IS26For and SHV5-IS26Rev for an IS26 insertion characteristic of the large SHV transposon, and Pr:IS26-F and Prquant-R for the promoter IS26 insertion characteristic of the small SHV transposon.
Sequencing templates were PCR amplified using the following thermocycling conditions: 35 cycles of 948C (30 s), 548C (30 s) and 728C (140 s). DNA sequencing reactions and capillary electrophoresis Figure 1 . Large and small SHV transposons, and the PCR primer sequences and their approximate annealing locations. The K. pneumoniae chromosome map is based upon the complete genome sequence of strain MGH78578 (GenBank accession number NC_009648), the large SHV transposon map is based upon the sequence of Escherichia coli plasmid p1658/97 8 and the small transposon map is based upon the sequence of Enterobacter cloacae plasmid pEC-IMPQ. 10 It should be noted that several examples of the small SHV transposon in GenBank are modified by insertion of another transposable element into the coding sequence of the downstream IS26. The large SHV transposon typically harbours a bla SHV encoding the non-ESBL SHV-1 or the ESBL derivatives SHV-2 (substitution at residue 238) or SHV-5 (substitutions at residues 238 and 240). The small SHV transposon typically harbours a bla SHV encoding the non-ESBL SHV-11 or the ESBL derivatives SHV-2a (substitution at residue 238) or SHV-12 (substitutions at residues 238 and 240). A comprehensive listing of SHV sequence variants is available at http://www.lahey.org/Studies/.
were carried out by the Australian Genome Research Facility (University of Queensland, Brisbane, Australia) and Bioscience North Australia (Charles Darwin University, Darwin, Australia).
A new bla SHV promoter sequence has been deposited in GenBank (accession number GQ489183).
Real-time reverse transcriptase PCR
RNA was isolated from 5 mL cultures grown to an optical density at 600 nm (OD 600 ) of 0.5. The cells were pelleted then resuspended in 1 mL of TRIZOL w reagent (Invitrogen Life Technologies, Paisley, Scotland, UK), then RNA extracted according to the manufacturer's instructions. DNA was removed using RNase-free DNase I (Fermentas, Murarrie, Australia) according to the manufacturer's instructions.
cDNA was synthesized from 1.5 mg of RNA using a SuperScript III Reverse Transcriptase kit (Invitrogen Life Technologies, Paisley, Scotland, UK) and primers SHVquantR and 16sAllBactR. bla SHV mRNA was quantified using a Corbett 6000 instrument, and primers SHVquantF and SHVquantR. 16S RNA ( primers 16sAllBactF and 16sAllBactR) was used for normalization. Each 10 mL reaction contained 5 mL of Platinum w SYBR w Green qPCR SuperMix-UDG (2Â; Invitrogen Life Technologies, Paisley, Scotland, UK), 0.5 mM of each primer and 1 mL of cDNA. The thermocycling was: 508C for 2 min, 958C for 7 min, 45 cycles of 958C for 10 s, 608C for 10 s and 728C for 10 s, and 608C for 30 s. Fluorescence acquisition was at 608C. Gene copy numbers were determined similarly, using genomic DNA as template. The threshold values were set within amplification exponential phase.
High resolution melting (HRM) curve analysis
HRM analyses were performed on Corbett Rotor-Gene 6000 instruments (Corbett Research, Sydney, Australia). A 97 bp bla SHV promoter fragment was amplified by primers prSHV_HRM_F and prSHV_HRM_R. Each 10 mL reaction contained 5 mL of Platinum w
SYBR
w Green qPCR SuperMix-UDG (2Â; Invitrogen Life Technologies), 0.5 mM of each primer, 3.5 mL of double-distilled water (ddH 2 O) and 1 mL of DNA template. The thermocycling was: 508C for 2 min, 958C for 2 min, 40 cycles of 958C for 5 s and 608C for 30 s, 728C for 2 min and 508C for 20 s, followed by temperature ramping from 68 to 808C with fluorescence acquisition every 0.058C. Reactions were performed in duplicate.
Results
A previously described mutation in the bla SHV promoter 210 region is associated with the large SHV transposon Eighteen isolates were assayed for the large and small SHV transposons, using PCRs for specific IS26 insertions ( Table 1) . The large SHV transposon-borne promoters were amplified from the six large SHV transposon-containing isolates using primers SHV-US and IS26-US (Figure 1) . The product was then used as a template for PCR using primers RecF-US and SHV-US. For the 12 large SHV transposon-free isolates, the product of RecF-US and SHV-US was amplified directly from genomic DNA. The amplified material was sequenced from both ends, which enabled sequencing of the promoters in both directions.
All of the promoter sequences derived from the large SHV transposon-negative isolates were identical to the complete genome of K. pneumoniae (GenBank accession number NC_009648). The sequences from the large SHV transposoncontaining isolates were identical to the bla SHV promoter sequence reported by Rice et al.
5 (Table 1) . This promoter has enhanced activity, due to a C!A mutation in the 210 region. These isolates were subjected to real-time reverse transcriptase PCR determination of bla SHV mRNA abundance. The co-existence of different bla SHV promoters in large SHV transposon-containing isolates was confirmed by sequencing the products of PCR amplification from genome extracts using primers RecF-US and SHV-US. As expected, the sequence traces had double C/A peaks at the 210 single nucleotide polymorphism (SNP), showing the presence of both promoter variants.
Presence of the large SHV transposon is indicative of enhanced bla SHV expression bla SHV mRNA levels were measured using real-time reverse transcriptase PCR, and DCt values were calculated as follows: DCt ¼ Ct (bla SHV cDNA) -Ct (16S cDNA). All six large SHV transposon-containing isolates and four of the large SHV transposon-free isolates were analysed ( Table 1 ). The mean DCt for the large SHV transposon-containing isolates was 14.32+1.41 cycles, which is significantly less (P,0.03) than the value for the SHV transposon-free isolates (19.38+0.72 cycles). Thus, the presence of the large SHV transposon increases bla SHV mRNA by $30Â. The DCt values for the genes themselves were not significantly different for isolates with and without the large SHV transposon (3.33+1.17 and 4.46+0.67 cycles, respectively). This confirms that the mutated promoter has enhanced activity.
An HRM-based method for interrogating the SNP in the 210 region of the bla SHV promoter
The HRM method for interrogating the bla SHV 210 SNP was tested against the isolates in Table 1 , and also another 50 K. pneumoniae isolates selected from the SENTRY collection that were also screened for SHV transposons (see Table S1 ). The promoter variants yielded easily resolved HRM curves [see Figure S1 , available as Supplementary data at JAC Online (http://jac.oxfordjournals.org)]. As expected, isolate 20, that carries the small SHV transposon, gave a result identical to the isolates devoid of SHV transposons because the HRM assay primers will not anneal to the promoter containing an IS26 insertion. There was complete consistency between the HRM data and the presence or absence of the large SHV transposon in all except three isolates. Isolate 232-28-D yielded an HRM curve intermediate between the known alleles (see Figure S1 ). Sequence analysis revealed a 'T' insertion in the 210 sequence, as compared with the unmutated promoter. For isolates 219-18-A and 236-52-A, no PCR product was obtained with the HRM primers.
Discussion
Consistent with this study, GenBank searches reveal that the large SHV transposon or modified derivatives always carry the mutated bla SHV promoter sequence, and this has been detected on plasmids harboured by K. pneumoniae, Yersinia pestis, Enterobacter cloacae and Salmonella enterica serovar Typhimurium 8, 9 (GenBank accession numbers AY532647 and AJ245670). We conclude that both the large and small SHV transposons possess strong bla SHV promoters, albeit generated by different mechanisms. This suggests that SHV ESBLs are plasmid associated in K. pneumoniae because an ESBL-conferring mutation in the poorly expressed chromosomal gene will not confer a phenotype. The detection of the large SHV transposon in ESBL-negative isolates in this study, and also in an ESBL-negative Y. pestis, 9 indicates that there has been dissemination of highly expressed, plasmid-borne non-ESBL-encoding bla SHV genes prior to the evolution of SHV ESBLs.
The association between the large SHV transposon and the mutated promoter expands the findings of Rice et al.
5 who determined that the mutant promoter was chromosomally located. It may be that the mutant promoter first appeared on the chromosome and was subsequently mobilized onto a plasmid, or that there have been parallel instances of the evolution of that promoter sequence, or that the gene has integrated back into the chromosome.
The HRM-based method developed for interrogating the bla SHV promoter SNP is a convenient means for detecting an extant mechanism for enhanced bla SHV expression and consequent increased potential to acquire an ESBL-positive phenotype.
